Cite
HARVARD Citation
Früh, M. et al. (2019). EGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in non-small-cell lung cancer. Annals of oncology. pp. 1190-1192. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Früh, M. et al. (2019). EGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in non-small-cell lung cancer. Annals of oncology. pp. 1190-1192. [Online].